Iran Distributes Iodine Tablets Near Nuclear Sites as Precaution Against a Possible Strike

The Library Media — National & World · World Desk

By Maya Wilson, World Desk Lead, The Library Media

Share

Published November 17, 2026 · 1:35 PM PT

Iran has been distributing iodine tablets to residents living near its nuclear facilities as a precaution against possible radioactive contamination if the sites are attacked, according to reporting published earlier this month. The distribution is a preparedness measure; there has been no new attack on Iran’s nuclear facilities and no evidence of a radiation leak.

The Times of London reported in November that an Iranian Health Ministry official described efforts to distribute the tablets to communities within a radius of two to three kilometres of nuclear facilities during wartime. The report focused attention on the heavily fortified Pickaxe Mountain complex near Natanz, amid fears of a possible U.S. attack on Iranian nuclear sites.

Separate reporting by Anadolu Agency on November 6, citing Iranian media, said approximately 180,000 iodine tablets had been distributed in Bushehr, in southern Iran. The distribution was conducted under an emergency plan decided by the national Crisis Management Headquarters. Bushehr is home to Iran’s only operational nuclear power plant.

The Bushehr University of Medical Sciences confirmed that distribution had been prioritised in the city and that the plan predated the June 2025 war. The initial focus was on communities near the Bushehr Nuclear Power Plant. The programme was later expanded to cover the whole city, with residents able to obtain tablets through comprehensive health centres.

Iranian officials have issued guidance on dosage according to age group and on when the tablets should be taken. The recommended timing is within a window extending from 24 hours before a potential incident to a few hours afterwards.

The preparations have attracted attention amid concern about the possibility of an attack on Iranian nuclear facilities. A safety video has also circulated on Iranian social media, advising citizens what to do in the event of possible radioactive contamination. The reporting does not indicate that an attack has occurred or that radioactive material has been released.

The tablets contain potassium iodide, a stable form of iodine. It works by saturating the thyroid gland with stable iodine, reducing the amount of radioactive iodine the gland can absorb if exposure occurs.

That protection is limited. Medical experts note that potassium iodide protects the thyroid against radioactive iodine, but does not protect against other radioactive substances or external radiation. It is not a general shield against radiation exposure.

World Health Organization guidance says potassium iodide should be taken only when instructed by medical or emergency authorities, and at the correct time and prescribed dose. Timing matters because taking the tablets too early or too late can reduce their protective effect.

Iran’s distribution programme therefore represents advance preparation for a possible emergency, rather than evidence that a nuclear incident is under way. The distinction is important: the reported measures reflect concern about potential contamination in the event of an attack, not a confirmed strike or radiation leak.

Maya Wilson
World Desk Lead, The Library Media

From The Library — the estate of our family.

Follow Us

X Facebook Instagram Threads Mastodon Bluesky

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top